Pay Bill Online Category: Latest News
I have macular degeneration: What do I do now?
What Is Macular Degeneration Age-related macular degeneration is a common degenerative condition of the retina that can produce “legal blindness,” usually in retirement age population. About one in 10 individuals in their 50s will display some changes of AMD, and about one in three in their 70s will display AMD changes. There is a definite… Read More
New Macular Degeneration Drug Tested Locally
Patricia Liscinsky of South Fort Myers knew there was something wrong with her vision while driving home from work at a local department store one night. She couldn’t read the street signs, especially at dusk. Her vision became worse day by day until she finally was no longer able to work nights at all. Then… Read More
18th Annual Vision Research Symposia
ThromboGenics Confirms JETREA US Launch Date of Monday January 14th, 2013
Leuven, Belgium – January 4, 2013 – ThromboGenics NV (Euronext Brussels: THR), an integrated biopharmaceutical company focused on developing and commercializing innovative ophthalmic medicines, confirms its JETREA® US launch date of Monday January 14th, 2013. JETREA® (ocriplasmin) Intravitreal Injection is a proteolytic enzyme indicated for the treatment of symptomatic vitreomacular adhesion (VMA). The US price… Read More
Can E-readers Help Your Macular Disease Patients?
Easier reading for those with visual deficits June 2011 Current treatments for macular disease are leading to gratifying results, saving much of the severe vision loss that was often unavoidable 10 years ago. Still, despite optimal treatment, many patients end up with a moderate level of visual impairment and complain of difficulty in accessing the… Read More
FDA approves drug for diabetics
NBC News FORT MYERS – AUGUST 10, 2012 Lucentis was approved by the FDA. Doctors are calling it a breakthrough drug for diabetic patients. It helps diabetics who have bleeding and swelling in the back of their eyes. The drug was tested out in a clinical study right here in Fort Myers. NBC-2.com WBBH News… Read More
National Medical Announcement Makes Drug More Affordable for Seniors
Retina Consultants of Southwest Florida is One of Two Florida Clinical Trial Sites May, 2011 Two drugs used to treat Age-Related Macular Degeneration (AMD) are equally effective, despite the fact that one (Lucentis) costs 40 times more than competitor Avastin, according to The National Eye Institute (NEI)of the National Institutes of Health.The NEI announcement has… Read More
FDA Approval of New Drug: Allergan’s Ozurdex
June 30, 2009 Dear Colleague, Retina Consultants of Southwest Florida®, along with our in-house research facility, the National Ophthalmic Research Institute™ (NORI), is proud to announce the U.S. Food and Drug Administration’s (FDA) approval of the first drug-therapy for macular edema due to retinal vein occlusion. Allergan’s Ozurdex just received FDA approval and will soon… Read More
Gulfshore’s Top Doctors
June 30, 2009 Dear Colleague, Because of the dedicated care you show the patients you share with us, we want to take this opportunity to thank you for allowing us the privilege to be recognized as Top Doctors again this year. Southwest Florida’s Top Doctors are selected by Gulfshore Life Magazine after extensive research by… Read More
